CN106520729A - Maltooligosyl trehalose hydrolase and expression gene and application thereof - Google Patents

Maltooligosyl trehalose hydrolase and expression gene and application thereof Download PDF

Info

Publication number
CN106520729A
CN106520729A CN201610937019.8A CN201610937019A CN106520729A CN 106520729 A CN106520729 A CN 106520729A CN 201610937019 A CN201610937019 A CN 201610937019A CN 106520729 A CN106520729 A CN 106520729A
Authority
CN
China
Prior art keywords
ala
leu
gly
asp
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610937019.8A
Other languages
Chinese (zh)
Other versions
CN106520729B (en
Inventor
王瑞明
薛乐平
王腾飞
汪俊卿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qilu University of Technology
Original Assignee
Qilu University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qilu University of Technology filed Critical Qilu University of Technology
Priority to CN201610937019.8A priority Critical patent/CN106520729B/en
Publication of CN106520729A publication Critical patent/CN106520729A/en
Application granted granted Critical
Publication of CN106520729B publication Critical patent/CN106520729B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/12Disaccharides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/14Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/011414-Alpha-D-{(1->4)-alpha-D-glucano} trehalose trehalohydrolase (3.2.1.141)

Abstract

The invention relates to a maltooligosyl trehalose hydrolase and an expression gene and an application thereof. The nucleotide sequence of maltooligosyl trehalose hydrolase expression gene MTHase is shown as a SEQ ID NO.3; and the amino acid sequence of maltooligosyl trehalose hydrolase MTHase is shown as a SEQ ID NO.4. The invention also relates to the application of maltooligosyl trehalose hydrolase expression gene MTHase in production of trehalose. The maltooligosyl trehalose hydrolase expression gene MTHase obtained by extracting Arthrobacter oxydans is firstly found, The maltooligosyl trehalose hydrolase expression gene MTHase expressed by gene is obviously better than the known maltooligosyl trehalose hydrolase MTHase, the enzyme and MTSase of Arthrobacter oxydans with same source are combined for action to produce trehalose, yield is high, and the maltooligosyl trehalose hydrolase has wide application prospect.

Description

Malt oligosaccharide based mycose hydrolytic enzyme and its expressing gene and application
Technical field
The present invention relates to malt oligosaccharide based mycose hydrolytic enzyme and its expressing gene and application, belong to technique for gene engineering neck Domain.
Background technology
Trehalose is a kind of safe irreducibility two being combined into by α -1,1 glycosidic bonds by two molecule glucoses Sugar, is widely present in plant, animal and microorganism.Trehalose has extensive biological significance, in medicine be it is a kind of very Good stabilizer, can be used to protect the thing of the easy in inactivation such as hormone, vitamin, antibiotic, biological preparation, enzyme, antiserum, vaccine Matter;Cell viability can be maintained in cosmetics, with moisturizing, radiation-resistant effect;Can maintain in agricultural crop high temperature, Normal growth under high drought, high salt conditions;It is used as improving the natural additive of quality and local flavor in food, while also having Fresh-keeping effect;Therefore " sugar of life " is described as in scientific circles.
The method of production trehalose mainly includes single enzyme process and two enzymes method at present.Single enzyme process mainly utilizes trehalose synthase Trehalose is generated by substrate of maltose, but the stability of the enzyme is poor, easily inactivates, it is not extensive using the technique at present The report of production trehalose.Two enzymes method is using malt oligosaccharide based mycose synthetase (MTSase), malt oligosaccharide based mycose Hydrolytic enzyme (MTHase), is directly catalyzed generation trehalose by substrate of amylose.MTSase major catalytic intramoleculars turn glycosyl α-Isosorbide-5-Nitrae-the glycosidic bond of the reducing end under neutral of starch is converted into α -1 by reaction, and 1- glycosidic bonds obtain intermediate product Fructus Hordei Germinatus oligose Base trehalose;α-Isosorbide-5-Nitrae-glycosidic bond that Fructus Hordei Germinatus oligose base is connected with trehalose in the MTHase single-minded inscribe intermediate product, produces The new Fructus Hordei Germinatus oligose of 2 glucose units of a raw molecule trehalose and reduction, and next round reaction is carried out as new substrate.Mesh Front two enzymes method is most economical practical process route, and is applied to industrialized production.
Malt oligosaccharide based mycose synthetase and malt oligosaccharide based mycose hydrolytic enzyme are most early in arthrobacterium Report is found in (Arthrobactor sp.StrainQ36), later again in root nodule bacteria (Rhizobium sp.Strain M11), micro- yellow brevibacterium (Brevibactierium helvolum), sulfolobus acidocaldarius (Sulfolobus Acidocaldarius ATCC33909) in be found that in succession both enzymes.The MTSase and MTHase of separate sources has not Same enzymatic property, 40 DEG C of the optimal reactive temperature of Arthrobactor sp.StrainQ36, pH6.5, high conversion rate reach 80%, Sulfolobus acidocaldarius ATCC33909 have 75 DEG C higher of optimal reactive temperature and relatively low PH 5.0, but enzyme activity is very low.
The content of the invention
The present invention is directed to the deficiencies in the prior art, there is provided malt oligosaccharide based mycose hydrolytic enzyme and its expressing gene with should With.
Technical solution of the present invention is as follows:
Malt oligosaccharide based mycose hydrolytic enzyme expressing gene MTHase, nucleotide sequence is as shown in SEQ ID NO.3.
Above-mentioned malt oligosaccharide based mycose hydrolytic enzyme MTHase, aminoacid sequence is as shown in SEQ ID NO.4.
A kind of recombinant expression carrier, inserts above-mentioned expressing gene MTHase in expression vector.
Preferably, the expression vector is expression vector pET-22b (+).
A kind of reconstitution cell, containing above-mentioned recombinant expression carrier.
Preferably, described reconstitution cell is by by after above-mentioned expression vector transformed competence colibacillus e. coli bl21 (DE3) Obtain.
Above-mentioned malt oligosaccharide based mycose hydrolytic enzyme MTHase, above-mentioned expressing gene MTHase, above-mentioned reconstitution cell are in system Application in standby production trehalose.
Beneficial effect
Present invention firstly discovers that the Fructus Hordei Germinatus oligose for obtaining is extracted by oxidation arthrobacterium (Arthrobacter oxydans) Base hydrolysis of trehalose expression of enzymes gene M THase, the malt oligosaccharide based mycose hydrolytic enzyme MTHase optimum temperatures of the gene expression For 57 DEG C, optimum pH 5.5 produces maltopentaose base trehalose by substrate of 20% maltopentaose, and enzyme activity can reach 35.7U/ml, Existing known malt oligosaccharide based mycose hydrolytic enzyme MTHase is significantly better than, the enzyme is with same from oxidation arthrobacterium During (Arthrobacter oxydans) collective effect production trehalose, yield is high, has broad application prospects.
Description of the drawings
Fig. 1 is the flow chart that MTSase, MTHase gene obtains process;
Fig. 2 is the electrophoresis detection result photo after the amplification of MTSase gene PCRs;
Fig. 3 is the electrophoresis detection result photo after the amplification of MTHase gene PCRs;
Specific embodiment
Technical scheme is described further with reference to embodiment, but institute's protection domain of the present invention is not limited to This.
Strain source
Oxidation arthrobacterium (Arthrobacter oxydans) is purchased from China General Microbiological collection (CGMCC), deposit number NO.1.1925.
Embodiment 1:The extraction of oxidation arthrobacterium (Arthrobacter oxydans) genome DNA.
By the oxidation arthrobacterium preserved at -80 DEG C (Arthrobacter oxydans) inoculation to LB fluid mediums In (peptone 10g/L, yeast powder 5g/L, NaCl 10g/L), activation culture 24 hours, is seeded to newly according to 1% inoculum concentration thereafter Cultivate 24 hours in fresh LB culture medium, take 10mL bacterium solutions and the method provided by work bacterial genomes extracts kit is given birth to according to Shanghai Extract the bacterium genome DNA.
Embodiment 2:The acquisition of MTSase, MTHase gene
The acquisition of MTSase, MTHase gene as shown in figure 1, according to homologous comparison separately design degenerate primer F1 and R1, F2 and R2.
F1:GGTTCCGSGTGSGASGTGAAGAACTGCCA
R1:TTGGCCATSACCATKCCSGAGGTCTGCTGGAA
F2:ATCTACGARCTSCACSTGGGCACCTT
R2:GGTTCCGSGTGSGASGTGAAGAACTGCCA
With genome DNA obtained in embodiment 1 as template, respectively with F1 (forward primer), R1 (downstream primer) and F2 (forward primer), R2 (downstream primer) are primer, are entered according to product description using the Ex TaqTM test kits of TaKaRa companies Performing PCR is expanded;
The PCR amplification system is as follows:
2 μ L of genomic DNA, 2 μ L of forward primer, 2 μ L of downstream primer, 25 μ L of Taq enzyme, ddH2O 19μL。
PCR conditions are:95 DEG C of degeneration 5min;95 DEG C of degeneration 30sec, 64 DEG C of annealing 30sec, 72 DEG C of extension 1min, totally 30 Individual circulation;72 DEG C of extension 10min, 4 DEG C of preservations.
Gel electrophoresiss respectively obtain two 1000bp or so band, and rubber tapping is reclaimed.PCR primer is carried with pTOPO-T respectively Body connection is transformed in DH5 α, selects positive colony, is delivered to Shanghai life work sequencing, is denoted as sequencing result 1.
According to sequencing result 1 and homologous sequence design degenerate primer F3 and R3, F4 and R4, F5 and R5.
F3:ACSCGGCGGTAGGGCATGGWTTC
R3:CCGGGCAGTGGAGCGACGACT
F4:CCCGCCGTAGCCTTCATGGAC
R4:ACCTCGGGAATGGTCATGGC
F5:CTTGTCCAGGTCGTCGTCCGAG
R5:CTTGTCCAGGTCGTCGTCCGAG
With genome DNA obtained in embodiment 1 as template, respectively with F3 (forward primer) and R3 (downstream primer), F4 (forward primer) and R4 (downstream primer), F5 (forward primer) and R5 (downstream primer) are primer, using the Ex of TaKaRa companies TaqTM test kits carry out into performing PCR expanding according to product description;
The PCR amplification system is as follows:
2 μ L of genomic DNA, 2 μ L of forward primer, 2 μ L of downstream primer, 25 μ L of Taq enzyme, ddH2O 19μL。
PCR conditions are:95 DEG C of degeneration 5min;95 DEG C of degeneration 30sec, 64 DEG C of annealing 30sec, 72 DEG C of extension 1.5min, altogether 30 circulations;72 DEG C of extension 10min, 4 DEG C of preservations;
Gel electrophoresiss respectively obtain 1000bp, 1000bp, 1500bp or so band, and rubber tapping is reclaimed.By PCR primer respectively with The connection of pTOPO-T carriers is transformed in DH5 α, selects positive colony, is delivered to Shanghai life work sequencing, is denoted as sequencing result 2.
MTSase and MTHase gene head and the tail base sequences, and destination carrier pET-22b are obtained according to sequencing result 2 Sequence, designs by primer-design software CE Design V1.03Seamless clone's multi-discSection chimera primers F 6 and R6, F7 and R7.Boldface is restriction enzyme site Nde I and Xho I.
F6:taagaaggagatataAGGGTCCCGGCATCCAC
R6:gtggtggtggtggtgTGCCTTTTCTCCATCCGCC
F7:taagaaggagatataATGACCCTCGTCAATGGCGG
R7:gtggtggtggtggtgGGATTTGACGATTGCCGCA
With genome DNA obtained in embodiment 1 as template, respectively with F6 (forward primer) and R6 (downstream primer), F7 (forward primer) and R7 (downstream primer) are primer, are entered according to product description using the Ex TaqTM test kits of TaKaRa companies Performing PCR is expanded;
The PCR amplification system is as follows:
2 μ L of genomic DNA, 2 μ L of forward primer, 2 μ L of downstream primer, 25 μ L of Taq enzyme, ddH2O 19μL。
PCR conditions are:95 DEG C of degeneration 5min;95 DEG C of degeneration 30sec, 55 DEG C of annealing 30sec, 72 DEG C of extension 2.5min, altogether 30 circulations;72 DEG C of extension 10min, 4 DEG C of preservations;
Gel electrophoresiss respectively obtain 2300bp and 1800bp or so band, as shown in Figure 2 and Figure 3, are consistent with theoretical value, cut Glue reclaim.
Embodiment 3:The structure of recombiant plasmid and conversion
By genes of interest MTSase, MTHase product after purification respectively with linearisation after carrier pET-22b (+)/ (Nde I, Xho I) connects, and linked system as shown in table 1, connection product is converted into e. coli bl21 competent cell, 37 DEG C of 200r/min cultivate 1h, subsequently transformed cells are coated on the LB flat boards containing 100 μ g/mL ampicillin, 37 DEG C Constant temperature incubated overnight, picking single bacterium colony simultaneously obtain positive colony by bacterium colony PCR screenings, deliver to Shanghai life work sequencing, as a result Show Insert Fragment respectively containing a long 2328bp (such as SEQ ID NO:Shown in 1) and 1770bp (such as SEQ ID NO:3 institutes Show) open reading frame (ORF), be separately encoded by the protein of 775 and 589 amino acid encodings.
Table 1:Linked system
Embodiment 4:The abduction delivering of recombinant bacterial strain
Recombinant bacterial strain E.coli BL21 (pET-22b-MTSase) and E.coli BL21 (pET-22b-MTHase) are pressed According to mass percent 1% inoculum concentration be inoculated into 50mL containing concentration be 100 μ g.mL-1The LB liquid cultures of ampicillin (Amp) In base, 37 DEG C are cultivated to OD600=0.8, after adding IPTG derivants, then proceed to 22 DEG C of constant-temperature shaking incubators and carry out induction table Reach.After induction 12h, collects thalline 5000r/min centrifugation 5min, adds the resuspended thalline of phosphate buffer of 10mL pH 6.47, Ultrasonication (power 300W, intermittent time 6s, broken time 4s, whole process 13min) is carried out, in 8000rpm centrifugation 10min collections Clear liquid is used as crude enzyme liquid.
The LB fluid mediums, every liter of component are as follows:
Peptone 10g/L, yeast extract 5g/L, NaCl 10g/L, pH 7.0~7.4;
Embodiment 5:Ni-NTA affinitive layer purifications
Taking-up is stored in the nickel post of 4 DEG C of refrigerators, will be ethanol in post complete with the resuspended filler of ethanol and after filler sinks completely Portion releases.With the Ni-Native-0 buffer balance filler of 5-10 times of volume, flow speed control is 1mL/min;Add embodiment 4 Gained crude enzyme liquid, keeps flow velocity 1mL/min 30min, collects effluent;With Ni-Native-100 buffer solution purpose eggs In vain, coutroi velocity is 1mL/min, and collects effluent;With Ni-Native-250 buffer solution destination proteins, flow velocity is 1mL/min, collects effluent;The Ni-Native-0 buffer balance pillar of 5-10 times of volume is added, and with percent by volume is 30% ethanol solution preserves filler, and the enzyme liquid sample collected carries out SDS-PAGE analyses, obtains MTSase's and MTHase Molecular weight is respectively 85000Da and 65000Da.
Embodiment 6:The measure of MTSase and MTHase enzyme activity
MTSase enzyme activity determinations:Maltopentaose is dissolved in the phosphoric acid-citrate buffer solution of 50m mol/L pH 5.5, The solution that mass concentration is 20% is made into, the 100mL solution is taken and is added 1mL MTSase enzyme liquids, 50 DEG C of reaction 10min, 100 DEG C Boil 10min terminating reactions.After solution cooling, pH4.2 is adjusted, add 0.1mL saccharifying enzyme, 50 DEG C of saccharifying 24h, HPLC to determine The amount of trehalose.
MTSase enzyme-activity units (U) are defined:Per 1min, conversion maltopentaose generates 1m mol maltopentaose base trehaloses institute The enzyme amount of needs.
MTHase enzyme activity determinations:Maltopentaose is dissolved in the phosphoric acid-citrate buffer solution of 50m mol/L pH 5.5, The solution that mass concentration is 20% is made into, 100mL solution addition 200U MTSase enzyme liquids are taken, 50 DEG C are reacted 5h, and 100 DEG C are boiled Boiling 10min terminating reactions.After solution cooling, regulation pH5.5, addition 1mL MTHase enzyme liquids, 50 DEG C of reaction 10min, 100 DEG C 10min terminating reactions are boiled, HPLC determines the amount of trehalose.
MTSase enzyme-activity units (U) are defined:Maltopentaose is hydrolyzed per 1min and generates the enzyme amount required for 1m mol trehaloses.
Jing is determined, and the enzyme activity of MTSase and MTHase is respectively 35.7U/mL and 80.2U/mL.
Embodiment 7:Application of the two enzymes method in trehalose
Soluble starch is dissolved in the phosphoric acid-citrate buffer solution of 50m mol/L, the shallow lake that mass concentration is 20% is made into Powder solution, 80 DEG C of gelatinizing 10min, addition α-amylase 100U (g starch)-1, 50 DEG C of reaction 10min, 120 DEG C of inactivation alphalise starch Enzyme, MTSase and MTHase crude enzyme liquids are added in starch solution, 60 DEG C of reaction 24h under conditions of pH5.5, trehalose Conversion ratio is 82.5%.
Two kinds of enzyme MTSase and MTHase of the present invention are compared with double enzymes that other are originated, with higher optimal reactive temperature 60 DEG C, and relatively low optimum pH 5.5, industrialized production is more suitable for, with starch solution that mass fraction is 20% as substrate, 24h is reacted under the conditions of double enzyme effects, conversion ratio may be up to 82.5%.
Comparative example:
Malt oligosaccharide based mycose hydrolytic enzyme (MTHase) and patent documentation CN103205475A (application numbers in the present invention 201310128939.1) react under conditions of in, the MTHase of embodiment 3-1 preparation is described in the embodiment of the present invention 6, this The enzyme activity of bright middle MTHase may be up to 80.2U/mL, higher than patent documentation CN103205475A (application number 201310128939.1) Described in MTHase enzyme activity 72.5U/mL.
Malt oligosaccharide based mycose synthetase (MTSase) and patent documentation CN103205475A (application numbers in the present invention 201310128939.1) in, malt oligosaccharide based mycose hydrolytic enzyme (MTHase) collective effect is in amylose, real in the present invention React under conditions of applying example 7, conversion ratio is only 70.5%;In the present invention, MTSase is common with the MTHase equally from the bacterial strain Same-action, conversion ratio may be up to 82.5%.
SEQUENCE LISTING
<110>Qilu University of Technology
<120>Malt oligosaccharide based mycose hydrolytic enzyme and its expressing gene and application
<160> 4
<170> PatentIn version 3.5
<210> 1
<211> 2328
<212> DNA
<213> Arthrobacter oxydans
<400> 1
atgagggtcc cggcatccac ctaccgactt cagatccgcc gcagcttcac cctgttcgac 60
gccgccgaca aggtcccgta cctcaaggac ctcggcgttg actgggtcta cctctcgccc 120
atcctcaccg cggagcaggg ctcggatcac ggctacgacg tgaccgaccc ctccgcggtg 180
gacccggagc ggggcggccc cgagggcctg ctggccctgt ccaaggctgc ccgcgagcac 240
ggcatgggtg tcctggtgga catcgtgccc aaccacgtgg gcgtagcgac gcccgtgcag 300
aacccctggt ggtggtccct gctgaaggaa gggcagggct cgccctacgc cgaagccttc 360
gacgtcgact gggacctggc aggcgggaag atccggctgc ccatgcttgg ctcggacgac 420
gacctggaca agcttgaaat caaggacggc gagctccgct actacgacca ccggttcccg 480
ctcgcttcgg gaagctactc ggagggcgac tccccccagg aagtgcacag ccggcagcac 540
tatgagctga tggactggcg ccgggcggac gccgaactga actaccggcg cttcttcgca 600
gtgaccacgt tggccgggat ccgggtggaa acccccaagg tcttcgagga agcacatgcc 660
gaggtgggcc gctggttcaa ggaaggcctg gtggacggcc tgcgggttga ccacccggac 720
ggcctggccg accccgccgg ctacctgcgc tggctgaagg acctcagcgg cggagcctac 780
gtcctggtgg aaaagatcct cgagccgggc gaaaccctgc cgcaggactt cgccaccgag 840
ggaaccaccg ggtacgacgc cctcgcggac gtggaccggg tgttcgtgga ccccgcaggc 900
cagcaggcgc tggacgagct cgacgcgaag cttcgcggct ccagcacccc cgcggactac 960
gcggagatga tcaggggcac caagcggatg atcgcggacg gcatcctgcg gtccgaggtc 1020
ctgcgcctgg cccgcctggt accggagtcc tatgggctgc cggtggagca ggcagcagat 1080
gccattgccg agatcatcgc tgccttcccg gtctaccgga cgtacctgcc caccggcgcc 1140
gagatcctca aggaagcgtg cgaatcagcg gcggcccacc ggcccgacct cgaggttgcc 1200
gtgggcaccc tgctgccgct gctccttgat cccgggaacc ccatcgcggt ccgcttccag 1260
cagacctcgg gaatggtcat ggccaagggc gtcgaggaca cggcgttcta ccgctacacc 1320
cgcctgggca ccctgacaga ggtgggggcc gaaccgacag agttctctgt ttccacggcc 1380
gagttccacc agcggatggc ccggcgccaa caggaacttc ccctgtccat gaccaccatg 1440
tccacgcatg acaccaagcg cagcgaggac gcccgggccc ggatctcggt catcgccgaa 1500
ctgccggagg agtgggcgga caccttggcc acgctccgcg gactcgcccc gattccggac 1560
ggcccctacg agaacctgct gtggcaggct gtggtggggg cttggcccgc aagcagggaa 1620
cgcctgcagg gctacgccga gaaggctgcc cgggaagccg gcaactccac cacctggacc 1680
agccccgacg aggacttcga atcctccgtc aaggccgcgg tggacgcagt gttcgacgac 1740
ggccgcgtca ccaaagcggt ggaggacttc gtggcacgga tcgattccta cgccgcgtcc 1800
aactccgtgt ccgccaagct ggtccagctg accatgcccg gcgtgccgga tgtttaccag 1860
ggcagcgagt tctgggaacg gtccctgacc gaccccgaca accggcggcc ggtggacttt 1920
gaagtccgcc ggcaggagct cgccaagctc gacgccggca ccctccccgc ggccggcacg 1980
gaacccagca agctcctggc cacgtcccgc gcgctccggc tccgccgcga ccggcccgaa 2040
ctgttccagg gctacagccc cgtgacagcc acgggcccgg cggcggatca cgtcctcgcg 2100
ttccaccgcg ggggtgacgg cgccctgggc gccctgaccc tggccacccg gcttcccgcc 2160
ggactcgcgg ccgacggcgg atggcgggac accgccgtcg agcttcccgt tgcggtgtgt 2220
gacgaactca ccggcaacgc ctacggaccc ggctccgttc cggtggccga ggtcctgggc 2280
acctaccccg tggcattgct cgtaccggcg gatggagaaa aggcatga 2328
<210> 2
<211> 775
<212> PRT
<213> Arthrobacter oxydans
<400> 2
Met Arg Val Pro Ala Ser Thr Tyr Arg Leu Gln Ile Arg Arg Ser Phe
1 5 10 15
Thr Leu Phe Asp Ala Ala Asp Lys Val Pro Tyr Leu Lys Asp Leu Gly
20 25 30
Val Asp Trp Val Tyr Leu Ser Pro Ile Leu Thr Ala Glu Gln Gly Ser
35 40 45
Asp His Gly Tyr Asp Val Thr Asp Pro Ser Ala Val Asp Pro Glu Arg
50 55 60
Gly Gly Pro Glu Gly Leu Leu Ala Leu Ser Lys Ala Ala Arg Glu His
65 70 75 80
Gly Met Gly Val Leu Val Asp Ile Val Pro Asn His Val Gly Val Ala
85 90 95
Thr Pro Val Gln Asn Pro Trp Trp Trp Ser Leu Leu Lys Glu Gly Gln
100 105 110
Gly Ser Pro Tyr Ala Glu Ala Phe Asp Val Asp Trp Asp Leu Ala Gly
115 120 125
Gly Lys Ile Arg Leu Pro Met Leu Gly Ser Asp Asp Asp Leu Asp Lys
130 135 140
Leu Glu Ile Lys Asp Gly Glu Leu Arg Tyr Tyr Asp His Arg Phe Pro
145 150 155 160
Leu Ala Ser Gly Ser Tyr Ser Glu Gly Asp Ser Pro Gln Glu Val His
165 170 175
Ser Arg Gln His Tyr Glu Leu Met Asp Trp Arg Arg Ala Asp Ala Glu
180 185 190
Leu Asn Tyr Arg Arg Phe Phe Ala Val Thr Thr Leu Ala Gly Ile Arg
195 200 205
Val Glu Thr Pro Lys Val Phe Glu Glu Ala His Ala Glu Val Gly Arg
210 215 220
Trp Phe Lys Glu Gly Leu Val Asp Gly Leu Arg Val Asp His Pro Asp
225 230 235 240
Gly Leu Ala Asp Pro Ala Gly Tyr Leu Arg Trp Leu Lys Asp Leu Ser
245 250 255
Gly Gly Ala Tyr Val Leu Val Glu Lys Ile Leu Glu Pro Gly Glu Thr
260 265 270
Leu Pro Gln Asp Phe Ala Thr Glu Gly Thr Thr Gly Tyr Asp Ala Leu
275 280 285
Ala Asp Val Asp Arg Val Phe Val Asp Pro Ala Gly Gln Gln Ala Leu
290 295 300
Asp Glu Leu Asp Ala Lys Leu Arg Gly Ser Ser Thr Pro Ala Asp Tyr
305 310 315 320
Ala Glu Met Ile Arg Gly Thr Lys Arg Met Ile Ala Asp Gly Ile Leu
325 330 335
Arg Ser Glu Val Leu Arg Leu Ala Arg Leu Val Pro Glu Ser Tyr Gly
340 345 350
Leu Pro Val Glu Gln Ala Ala Asp Ala Ile Ala Glu Ile Ile Ala Ala
355 360 365
Phe Pro Val Tyr Arg Thr Tyr Leu Pro Thr Gly Ala Glu Ile Leu Lys
370 375 380
Glu Ala Cys Glu Ser Ala Ala Ala His Arg Pro Asp Leu Glu Val Ala
385 390 395 400
Val Gly Thr Leu Leu Pro Leu Leu Leu Asp Pro Gly Asn Pro Ile Ala
405 410 415
Val Arg Phe Gln Gln Thr Ser Gly Met Val Met Ala Lys Gly Val Glu
420 425 430
Asp Thr Ala Phe Tyr Arg Tyr Thr Arg Leu Gly Thr Leu Thr Glu Val
435 440 445
Gly Ala Glu Pro Thr Glu Phe Ser Val Ser Thr Ala Glu Phe His Gln
450 455 460
Arg Met Ala Arg Arg Gln Gln Glu Leu Pro Leu Ser Met Thr Thr Met
465 470 475 480
Ser Thr His Asp Thr Lys Arg Ser Glu Asp Ala Arg Ala Arg Ile Ser
485 490 495
Val Ile Ala Glu Leu Pro Glu Glu Trp Ala Asp Thr Leu Ala Thr Leu
500 505 510
Arg Gly Leu Ala Pro Ile Pro Asp Gly Pro Tyr Glu Asn Leu Leu Trp
515 520 525
Gln Ala Val Val Gly Ala Trp Pro Ala Ser Arg Glu Arg Leu Gln Gly
530 535 540
Tyr Ala Glu Lys Ala Ala Arg Glu Ala Gly Asn Ser Thr Thr Trp Thr
545 550 555 560
Ser Pro Asp Glu Asp Phe Glu Ser Ser Val Lys Ala Ala Val Asp Ala
565 570 575
Val Phe Asp Asp Gly Arg Val Thr Lys Ala Val Glu Asp Phe Val Ala
580 585 590
Arg Ile Asp Ser Tyr Ala Ala Ser Asn Ser Val Ser Ala Lys Leu Val
595 600 605
Gln Leu Thr Met Pro Gly Val Pro Asp Val Tyr Gln Gly Ser Glu Phe
610 615 620
Trp Glu Arg Ser Leu Thr Asp Pro Asp Asn Arg Arg Pro Val Asp Phe
625 630 635 640
Glu Val Arg Arg Gln Glu Leu Ala Lys Leu Asp Ala Gly Thr Leu Pro
645 650 655
Ala Ala Gly Thr Glu Pro Ser Lys Leu Leu Ala Thr Ser Arg Ala Leu
660 665 670
Arg Leu Arg Arg Asp Arg Pro Glu Leu Phe Gln Gly Tyr Ser Pro Val
675 680 685
Thr Ala Thr Gly Pro Ala Ala Asp His Val Leu Ala Phe His Arg Gly
690 695 700
Gly Asp Gly Ala Leu Gly Ala Leu Thr Leu Ala Thr Arg Leu Pro Ala
705 710 715 720
Gly Leu Ala Ala Asp Gly Gly Trp Arg Asp Thr Ala Val Glu Leu Pro
725 730 735
Val Ala Val Cys Asp Glu Leu Thr Gly Asn Ala Tyr Gly Pro Gly Ser
740 745 750
Val Pro Val Ala Glu Val Leu Gly Thr Tyr Pro Val Ala Leu Leu Val
755 760 765
Pro Ala Asp Gly Glu Lys Ala
770 775
<210> 3
<211> 1770
<212> DNA
<213> Arthrobacter oxydans
<400> 3
atgaccctcg tcaatggcgg gcccgagcgc ttcgacgtct gggctcccga cgctaaatcc 60
gtgatactgc tggccggcgg ccagcagtat cccatggagg aaaaggacac ggcgcctggc 120
tctgaaggct ggtggacagc cccggacgct ccgggtggcg gtgaggtgga ctacggctac 180
ctgctggacg gtgacagtca cccagttccc gatccgcggt cgcgccgcct gcccgccggc 240
gtccatgagc tctccaggac gttcgacccc gcagcccacg cctggcagga ctccggctgg 300
aagggcaagg agctgaaggg ttcggtaatc tacgaactcc acatcggcac cttcacccct 360
gagggaaccc ttgacgctgc agccgaaaag ctcggctacc ttgcggacct gggaatcgac 420
tttgtcgagc tgctcccggt caatggcttc aacgggaccc acaactgggg ctacgacggc 480
gtccagtggt acgcggtcca tgaaggctac ggcgggcctg cggcctacca gcgctttgtg 540
gatgctgccc acgccgccgg cctgggcgtc atccaggacg tggtgtacaa ccacctcggc 600
ccgagcggaa actacctgtc caagttcggc ccgtacctga aacaggggga tgccaacacc 660
tggggtgact ccgtgaacct ggacggtccc ggctccgacg tggtgcggga atacatcctg 720
gacaaccttg ccctctggct ccgggattac cacgtggacg gcctccgcct ggacgccgtg 780
cacgcgctga aggacgagcg cgccgtgcac atccttgagg agttcggggc cctgggcgac 840
gccgtctcgg cggagaccgg gctgccgaag accctgattg ccgagtcgga cctgaacaac 900
ccccgcctgc tttacccgcg ggacgtcaac gggtacgggc tggccgggca gtggagcgac 960
gacttccacc acgcggtcca cgtcagcgtc agcggcgaga ccaccgggta ctacgaggac 1020
ttccagtccc tggcggtgct ggcaaaggtc ctgaaggacg gcttcctgca cgacggcagc 1080
tactccagct tccgcggccg gcaccacggc cggcctatca atgcctcgct ggtgcaccct 1140
gcggcgctgg tggtctgcaa ccagaaccac gaccagatcg gcaaccgcgc cacgggggac 1200
aggctctcgc agtcgctgtc ccacgggcag ctggccgtgg ccgccgtgct caccctgacg 1260
tccccgttca cgcccatgct gttcatgggc gaggagtttg cggccagcac cccttggcag 1320
ttcttcacct cccacccgga gccggagctg ggcaaggcta ccgcggaagg ccggatcaag 1380
gagttcgagc gcatggggtg ggatcccgcc gtcgtgcccg acccccagga tccggaaacc 1440
ttccgccggt ccaagctgga ctggaacgag tcctcaggcg gggaccacgc acggctcctg 1500
gagctttacc gctccctcac ggcgctgcgc cgcgggcacc ccgagcttgc cgggctcggc 1560
ttcaccgaga cggacgtgac gttcgacgac gacgccggct ggccgcgttt ccgccgcgga 1620
agcgttgagg tactgctgaa cctctcagac gccaaggtgc ggctggagga cgtttccggg 1680
acggtgctgc ttgcaacgga cgagggaacc ggccttgacg gcgaggccct cgccctggcg 1740
ccctggagtg cggcaatcgt caaatcctga 1770
<210> 4
<211> 589
<212> PRT
<213> Arthrobacter oxydans
<400> 4
Met Thr Leu Val Asn Gly Gly Pro Glu Arg Phe Asp Val Trp Ala Pro
1 5 10 15
Asp Ala Lys Ser Val Ile Leu Leu Ala Gly Gly Gln Gln Tyr Pro Met
20 25 30
Glu Glu Lys Asp Thr Ala Pro Gly Ser Glu Gly Trp Trp Thr Ala Pro
35 40 45
Asp Ala Pro Gly Gly Gly Glu Val Asp Tyr Gly Tyr Leu Leu Asp Gly
50 55 60
Asp Ser His Pro Val Pro Asp Pro Arg Ser Arg Arg Leu Pro Ala Gly
65 70 75 80
Val His Glu Leu Ser Arg Thr Phe Asp Pro Ala Ala His Ala Trp Gln
85 90 95
Asp Ser Gly Trp Lys Gly Lys Glu Leu Lys Gly Ser Val Ile Tyr Glu
100 105 110
Leu His Ile Gly Thr Phe Thr Pro Glu Gly Thr Leu Asp Ala Ala Ala
115 120 125
Glu Lys Leu Gly Tyr Leu Ala Asp Leu Gly Ile Asp Phe Val Glu Leu
130 135 140
Leu Pro Val Asn Gly Phe Asn Gly Thr His Asn Trp Gly Tyr Asp Gly
145 150 155 160
Val Gln Trp Tyr Ala Val His Glu Gly Tyr Gly Gly Pro Ala Ala Tyr
165 170 175
Gln Arg Phe Val Asp Ala Ala His Ala Ala Gly Leu Gly Val Ile Gln
180 185 190
Asp Val Val Tyr Asn His Leu Gly Pro Ser Gly Asn Tyr Leu Ser Lys
195 200 205
Phe Gly Pro Tyr Leu Lys Gln Gly Asp Ala Asn Thr Trp Gly Asp Ser
210 215 220
Val Asn Leu Asp Gly Pro Gly Ser Asp Val Val Arg Glu Tyr Ile Leu
225 230 235 240
Asp Asn Leu Ala Leu Trp Leu Arg Asp Tyr His Val Asp Gly Leu Arg
245 250 255
Leu Asp Ala Val His Ala Leu Lys Asp Glu Arg Ala Val His Ile Leu
260 265 270
Glu Glu Phe Gly Ala Leu Gly Asp Ala Val Ser Ala Glu Thr Gly Leu
275 280 285
Pro Lys Thr Leu Ile Ala Glu Ser Asp Leu Asn Asn Pro Arg Leu Leu
290 295 300
Tyr Pro Arg Asp Val Asn Gly Tyr Gly Leu Ala Gly Gln Trp Ser Asp
305 310 315 320
Asp Phe His His Ala Val His Val Ser Val Ser Gly Glu Thr Thr Gly
325 330 335
Tyr Tyr Glu Asp Phe Gln Ser Leu Ala Val Leu Ala Lys Val Leu Lys
340 345 350
Asp Gly Phe Leu His Asp Gly Ser Tyr Ser Ser Phe Arg Gly Arg His
355 360 365
His Gly Arg Pro Ile Asn Ala Ser Leu Val His Pro Ala Ala Leu Val
370 375 380
Val Cys Asn Gln Asn His Asp Gln Ile Gly Asn Arg Ala Thr Gly Asp
385 390 395 400
Arg Leu Ser Gln Ser Leu Ser His Gly Gln Leu Ala Val Ala Ala Val
405 410 415
Leu Thr Leu Thr Ser Pro Phe Thr Pro Met Leu Phe Met Gly Glu Glu
420 425 430
Phe Ala Ala Ser Thr Pro Trp Gln Phe Phe Thr Ser His Pro Glu Pro
435 440 445
Glu Leu Gly Lys Ala Thr Ala Glu Gly Arg Ile Lys Glu Phe Glu Arg
450 455 460
Met Gly Trp Asp Pro Ala Val Val Pro Asp Pro Gln Asp Pro Glu Thr
465 470 475 480
Phe Arg Arg Ser Lys Leu Asp Trp Asn Glu Ser Ser Gly Gly Asp His
485 490 495
Ala Arg Leu Leu Glu Leu Tyr Arg Ser Leu Thr Ala Leu Arg Arg Gly
500 505 510
His Pro Glu Leu Ala Gly Leu Gly Phe Thr Glu Thr Asp Val Thr Phe
515 520 525
Asp Asp Asp Ala Gly Trp Pro Arg Phe Arg Arg Gly Ser Val Glu Val
530 535 540
Leu Leu Asn Leu Ser Asp Ala Lys Val Arg Leu Glu Asp Val Ser Gly
545 550 555 560
Thr Val Leu Leu Ala Thr Asp Glu Gly Thr Gly Leu Asp Gly Glu Ala
565 570 575
Leu Ala Leu Ala Pro Trp Ser Ala Ala Ile Val Lys Ser
580 585

Claims (7)

1. malt oligosaccharide based mycose hydrolytic enzyme expressing gene MTHase, nucleotide sequence is as shown in SEQ ID NO.3.
2. malt oligosaccharide based mycose hydrolytic enzyme MTHase described in claim 1, aminoacid sequence is as shown in SEQ ID NO.4.
3. a kind of recombinant expression carrier, it is characterised in that expressing gene described in claim 1 is inserted in expression vector MTHase。
4. recombinant expression carrier as claimed in claim 3, it is characterised in that the expression vector is expression vector pET-22b (+)。
5. a kind of reconstitution cell, containing above-mentioned recombinant expression carrier.
6. reconstitution cell as claimed in claim 5, it is characterised in that described reconstitution cell is by above-mentioned expression vector is turned Change competence e. coli bl21 (DE3) to obtain afterwards.
7. malt oligosaccharide based mycose hydrolytic enzyme MTHase described in expressing gene MTHase, claim 2 described in claim 1, Application of the reconstitution cell described in claim 5 in production trehalose is prepared.
CN201610937019.8A 2016-10-25 2016-10-25 Malt oligosaccharide based mycose hydrolase and its expressing gene and application Active CN106520729B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610937019.8A CN106520729B (en) 2016-10-25 2016-10-25 Malt oligosaccharide based mycose hydrolase and its expressing gene and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610937019.8A CN106520729B (en) 2016-10-25 2016-10-25 Malt oligosaccharide based mycose hydrolase and its expressing gene and application

Publications (2)

Publication Number Publication Date
CN106520729A true CN106520729A (en) 2017-03-22
CN106520729B CN106520729B (en) 2019-11-26

Family

ID=58292174

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610937019.8A Active CN106520729B (en) 2016-10-25 2016-10-25 Malt oligosaccharide based mycose hydrolase and its expressing gene and application

Country Status (1)

Country Link
CN (1) CN106520729B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111041016A (en) * 2019-12-12 2020-04-21 云南师范大学 Salt-tolerant trehalose hexaphosphate hydrolase as well as preparation method and application thereof
CN112553268A (en) * 2020-11-10 2021-03-26 南宁汉和生物科技股份有限公司 Method and device for synthesizing trehalose by using ultrasonic-assisted enzyme

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164723A1 (en) * 1997-11-26 2002-11-07 Novozymes A/S Method of producing saccharide preparations
CN103194434A (en) * 2013-04-15 2013-07-10 山东天力药业有限公司 Novel sulfolobus solfataricus trehalose hydrolase, gene of hydrolase, recombinant expression vector containing gene, and recombinant bacterium, and preparation of hydrolase
CN103205475A (en) * 2013-04-15 2013-07-17 山东天力药业有限公司 Novel application of malt oligosaccharide based mycose synthetase and malt oligosaccharide based mycose hydrolase in mycose production
CN103952453A (en) * 2014-05-20 2014-07-30 彭燕辉 Method for preparing trehalose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164723A1 (en) * 1997-11-26 2002-11-07 Novozymes A/S Method of producing saccharide preparations
CN103194434A (en) * 2013-04-15 2013-07-10 山东天力药业有限公司 Novel sulfolobus solfataricus trehalose hydrolase, gene of hydrolase, recombinant expression vector containing gene, and recombinant bacterium, and preparation of hydrolase
CN103205475A (en) * 2013-04-15 2013-07-17 山东天力药业有限公司 Novel application of malt oligosaccharide based mycose synthetase and malt oligosaccharide based mycose hydrolase in mycose production
CN103952453A (en) * 2014-05-20 2014-07-30 彭燕辉 Method for preparing trehalose

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111041016A (en) * 2019-12-12 2020-04-21 云南师范大学 Salt-tolerant trehalose hexaphosphate hydrolase as well as preparation method and application thereof
CN111041016B (en) * 2019-12-12 2022-01-28 云南师范大学 Salt-tolerant trehalose hexaphosphate hydrolase as well as preparation method and application thereof
CN112553268A (en) * 2020-11-10 2021-03-26 南宁汉和生物科技股份有限公司 Method and device for synthesizing trehalose by using ultrasonic-assisted enzyme
CN112553268B (en) * 2020-11-10 2023-10-03 南宁汉和生物科技股份有限公司 Method and device for synthesizing trehalose by ultrasound-assisted enzyme

Also Published As

Publication number Publication date
CN106520729B (en) 2019-11-26

Similar Documents

Publication Publication Date Title
CN108034645B (en) Preparation and application of cyclodextrin glucosyltransferase mutant
CN103205475B (en) Novel application of malt oligosaccharide based mycose synthetase and malt oligosaccharide based mycose hydrolase in mycose production
CN109486794B (en) Chitinase mutant with improved enzyme activity
CN107488641B (en) A kind of malt oligosaccharide based mycose synthetase mutant and its application
CN110066777B (en) Endo-inulase and application thereof in production of fructo-oligosaccharide
CN102676480A (en) Method for producing extracellular pullulanase by applying auto-induction culture medium and dual-temperature control strategy
CN111218467B (en) Construction and application of MTHase and MTSase synchronously secreted recombinant bacillus subtilis
CN106434715B (en) Malt oligosaccharide based mycose synthetase and its expressing gene and application
CN102796751A (en) Mutant Pul 324 of pullulanibacillus naganoensis pullulanase and use thereof
CN105039374B (en) A kind of starch induction type recombined bacillus subtilis and preparation method and application
CN103103206B (en) Alpha-amylase and gene of alpha-amylase, engineering bacteria containing gene and application of engineering bacteria
CN110229774B (en) Arginine decarboxylase gene engineering bacterium and high-density fermentation culture method thereof
CN109022396B (en) Alpha-amylase mutant with improved enzyme activity and application thereof
CN106520729B (en) Malt oligosaccharide based mycose hydrolase and its expressing gene and application
CN113073074B (en) Genetically engineered bacterium for efficiently synthesizing riboflavin and application thereof
CN106754776A (en) The GDH mutant that a kind of specific enzyme activity for being catalyzed xylose is improved
CN103194434B (en) Novel sulfolobus solfataricus trehalose hydrolase, gene of hydrolase, recombinant expression vector containing gene, and recombinant bacterium, and preparation of hydrolase
CN107201373B (en) A kind of maltogenic amylase and its gene, the engineering bacteria containing the gene and its application
CN101503678B (en) Malt oligosaccharide based mycose synthetase, coding gene and use
CN101372693A (en) Heat resisting cellulase gene, recombinant engineering bacterium, heat resisting cellulase and use
CN108103049B (en) Thermophilic L-asparaginase mutant and screening and fermenting method thereof
CN105112348B (en) A kind of recombination bacillus pumilus of high yield Pullulanase and its application
CN106244566B (en) A kind of chondroitin synthase mutant and its application
CN111944784B (en) Maltogenic oligosaccharide based seaweed hydrolase mutant with improved heat stability and application thereof
CN114836397A (en) Cyclodextrin glucosyltransferase mutant and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant